J . Org. Chem. 2001, 66, 7691-7695
7691
Electr olytic P a r tia l F lu or in a tion of Or ga n ic Com p ou n d s. 55.1
High ly Regio- a n d Ster eoselective An od ic Mon oflu or in a tion of
2
,3-Dih yd r och r om a n -4-on e a n d Ch r om on e Der iva tives
Kamal M. Dawood†,‡ and Toshio Fuchigami*,†
Department of Electronic Chemistry, Tokyo Institute of Technology, 4259 Nagatsuta,
Midori-ku, Yokohama 226-8502, J apan, and Department of Chemistry, Faculty of Science,
Cairo University, Giza, Egypt
Received May 29, 2001
Anodic monofluorination at the position R to the oxygen atom of the (E)-3-benzylidene-2,3-dihy-
drochroman-4-one derivatives was successfully carried out to provide the corresponding 2-fluoro-
chromanones selectively. This is the first regioselective electrochemical fluorination of fused-type,
oxygen-containing heterocyclic compounds. Anodic fluorination of a chromone derivative also gave
a similar fluorinated chromanone stereoselectively.
In tr od u ction
synthetic routes to fluorinated heterocycles. The advan-
tageous electrochemical method has been profoundly
proven to be more applicable than the conventional,
The chroman-4-one moiety is an integral part of many
natural products. Chroman-4-one derivatives have also
2
hazardous chemical methods.1
0-12
Recently, we developed
drawn much attention due to their anti-human-immu-
1
3
the selective anodic fluorination of flavones and aryl-
thioethylenecarbonates14 as examples of oxygen-contain-
ing heterocycles. Crown ethers were also anodically
fluorinated; however, R,ω-difluoro products due to ring
opening were formed. On the other hand, furan, ben-
zofuran,16 and morpholines were anodically fluorinated;
however, their fluorinated products were either not
isolable due to their instability or isolable in very poor
yields with low selectivity.
3
nodeficiency-virus (HIV-1), that causes acquired immune
4
deficiency syndrome, and broad pharmacological activi-
ties. Moreover, the biological potency of fluorinated
heterocycles has been widely documented.5
-95-9
There-
1
5
fore, considerable efforts have been paid to explore new
17
*
To whom correspondence should be addressed. Tel/Fax: +81-45-
9
24-5406.
†
Tokyo Institute of Technology.
‡
Cairo University.
(
1) Part 54: Dawood, K. M.; Ishii, H.; Fuchigami, T. J . Org. Chem.
These results prompted us to conduct, for the first time,
a successful highly regioselective anodic direct fluorina-
tion at the position R to the ring oxygen atom of the
2
001, 66, 7030.
2) (a) Pohler, P.; Tamm, C. Tetrahedron Lett. 1967, 3479. (b)
(
Sidwell, W. T. L.; Tamm, C. Tetrahedron Lett. 1970, 475. (c) Mcpherson,
D. D.; Cordell, G. A.; Soejarto, D. D.; Pezzuto, J . M.; Fong, H. H. S.
Phytochemistry 1983, 22, 2835. (d) Chenera, B.; West, M. L.; Finkel-
stein, J . A.; Dreyer, G. B. J . Org. Chem. 1993, 58, 5605. (e) Tsui, W.
Y.; Brown, G. D. Phytochemistry 1996, 43, 871. (f) Crouch, N. R.;
Bangani, V.; Mulholland, D. A. Phytochemistry 1999, 51, 943. (g)
Bangani, V.; Crouch, N. R.; Mulholland, D. A. Phytochemistry 1999,
1
8
biologically active chroman-4-one derivatives 2a -c.
Resu lts a n d Discu ssion
Syn th esis of Sta r tin g Ch r om a n -4-on e a n d Ch r o-
m on e Der iva tives 2 a n d 3. When an equimolar amount
of chroman-4-one (1) and the appropriate aromatic alde-
hyde were heated at 80-90 °C, in the presence of a cat-
alytic amount of piperidine, the corresponding (E)-3-ben-
5
1, 947.
3) (a) Flavin, M. T.; Rizzo, J . D.; Khilevich, A.; Kucherenko, A.;
(
Sheinkman, A. K.; Vilaychack, V.; Lin, L.; Chen, W.; Greenwood, E.
M.; Pengsuparp, T.; Pezzuto, J . M.; Hughes, S. H.; Flavin, T. M.;
Cibulski, M.; Boulanger, W. A.; Shone, R. L.; Xu, Z. Q. J . Med. Chem.
1
996, 39, 1303. (b) Xu, Z. Q.; Bucheit, R. W.; Stup, T. L.; Flavin, M.
1
9
T.; Khilevich, A.; Rezzo, J . D.; Lin, L.; Zembower, D. E. Bioorg. Med.
Chem. Lett. 1998, 8, 2179. (c) Ishikawa, T.; Oku, Y.; Tanaka, T.;
Kumamoto, T. Tetrahedron Lett. 1999, 40, 3777.
zylidene-2,3-dihydrochroman-4-one derivatives 2a -c
were obtained in good yields. However, heating of 1 with
(
4) (a) Al-Nakib, T.; Bezjak, V.; Meegan, M. J .; Chandy, R. Eur. J .
Med. Chem. 1990, 25, 455. (b) Kataoka, K. I.; Shiota, T.; Takeyasu,
T.; Muchizuki, T.; Taneda, K.; Ota, M.; Hanabe, H.; Yamaguchi, Y. J .
Med. Chem. 1995, 38, 3174. (c) Bruno, O.; Schenone, S.; Ranise, A.;
Bondavilli, F.; D ´ı Amico, M.; Filippili, W.; Berrino, L.; Rossi, F. Farmaco
996, 51, 137. (d) Harlow, G. R.; Halpert, J . R. J . Biol. Chem. 1997,
72, 5396. (e) Kitajima, J .; Ishikawa, T.; Tanaka, Y.; Ida, Y. Chem.
(9) Hiyama, T. Organofluorine Compounds: Chemistry and Ap-
plications; Springer: Berlin, 2000.
(10) Fuchigami, T. In Advances in Electron-Transfer Chemistry;
Mariano, P. S., Ed.; J AI Press: Greenwich, CT, 1999; Vol. 6.
(11) Fuchigami, T.; Higashiya, S.; Hou, Y.; Dawood, K. M. Rev.
Heteroat. Chem. 1999, 19, 67.
1
2
Pharm. Bull. 1999, 47, 1448.
5) Walker, S. B. Fluorine Compounds as Agrochemicals; Fluoro-
chem Limited: Glossop, 1989.
6) (a) Biomedicinal Aspects of Fluorine Chemistry; Filler, R.,
Kobayashi, Y., Eds.; Kondansha & Elsevier Biomedical: Tokyo, 1982.
b) Welch, J . T.; Eswarakrishnan, S. Fluorine in Bioorganic Chemistry;
(12) Fuchigami, T. In Organic Electrochemistry, 4th ed.; Lund, H.,
Hammerich, O., Eds.; Dekker: New York, 2001; pp 1035-1050.
(13) Hou, Y.; Higashiya, S.; Fuchigami, T. J . Org. Chem. 1999, 64,
3346.
(14) Ishii, H.; Yamada, N.; Fuchigami, T. Chem. Commun. 2000,
1617.
(15) (a) Hou, Y.; Fuchigami, T. Tetrahedron Lett. 1999, 40, 7819.
(b) Ishii, H.; Hou, Y.; Fuchigami, T. Tetrahedron 2000, 56, 8877.
(16) Meurs, J . H.; Eilenberg, W. Tetrahedron 1991, 47, 705.
(17) Gambaretto, G. B.; Napoli, M.; Franccaro, C.; Conte, L. J . J .
Fluorine Chem. 1982, 19, 427.
(18) Dawood, K. M.; Fuchigami, T. Tetrahedron Lett. 2001, 42, 2513.
(19) Levai, A.; Schag, J . B. Pharmazie 1979, 34, 749.
(
(
(
Wiley: New York, 1991. (c) Biomedical Frontiers of Fluorine Chemistry;
Ojima, I., McCarthy, J . R., Welch, J . T., Eds.; ACS Symposium Series
6
39; American Chemical Society: Washington, DC, 1996.
7) Yoshioka, H.; Nakayama, C.; Matsuo, N. J . Synth. Org. Chem.
J pn. 1984, 42, 809.
8) Narizuka, S.; Fuchigami, T. Bioorg. Med. Chem. Lett. 1995, 5,
293.
(
(
1
1
0.1021/jo0105437 CCC: $20.00 © 2001 American Chemical Society
Published on Web 10/17/2001